MedPath

A trial comparing LED versus CFL phtototherapy in treating jaundice in preterm newborn babies

Not Applicable
Completed
Conditions
Health Condition 1: K768- Other specified diseases of liver
Registration Number
CTRI/2018/09/015734
Lead Sponsor
Mehta multi speciality hospitals pvt ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
78
Inclusion Criteria

Preterm neonates between 30 to 36+6 weeks of gestation with hyperbilirubinemia requiring phototherapy as per NICE guidelines for phototherapy

Exclusion Criteria

1.Neonates with major congenital malformations

2.APGAR scores less than 4 at 5 min

3.Onset of jaundice within the first 24 h of life,

4.Total serum bilirubin (TSB) is within or 2mg/dl below the exchange transfusion range

5.Hemolytic cause of jaundice (positive Coombsâ?? test,reticulocyte count >6 %, ABO ,Rh isoimmunization)

6.Direct bilirubin >20 % of total bilirubin or direct bilirubin >1mg/dL

7.Non availability of phototherapy unit at the time of randomization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath